Xingxing Zang

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Norihiko Watanabe, Maya Gavrieli, John R. Šedý et al. · Nature Immunology · 2003 · 863 citations

Lymphocyte Inhibitory Receptor, Autoimmune Disease, Immunology +7

Molecular Pathways: Targeting B7-H3 (CD276) for Human Cancer Immunotherapy

Élodie Picarda, Kim C. Ohaegbulam, Xingxing Zang · Clinical Cancer Research · 2016 · 547 citations

Molecular Features of Cancer-associated Fibroblast Subtypes and their Implication on Cancer Pathogenesis, Prognosis, and Immunotherapy Resistance

Phillip M. Galbo, Xingxing Zang, Deyou Zheng · Clinical Cancer Research · 2021 · 412 citations · Full text

B7x: A widely expressed B7 family member that inhibits T cell activation

Xingxing Zang, P’ng Loke, Jayon Kim et al. · Proceedings of the National Academy of Sciences · 2003 · 410 citations · Full text

B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome

Xingxing Zang, R. Houston Thompson, Hikmat Al‐Ahmadie et al. · Proceedings of the National Academy of Sciences · 2007 · 396 citations · Full text